Table 1.
Demographic profile of study patients (N=22,770)
| Variables | Stroke | Nonstroke | t/χ2 | p-value |
|---|---|---|---|---|
|
| ||||
| (n=11,385) | (n=11,385) | |||
| Age (years) | 73.41±8.18 | 73.41±8.18 | 0.000 | 1.000 |
| 60–69 | 4,024 (35.3) | 4,024 (35.3) | 0.000 | 1.000 |
| 70–79 | 4,527 (39.8) | 4,527 (39.8) | ||
| 80–89 | 2,531 (22.1) | 2,531 (22.1) | ||
| 90–99 | 303 (2.7) | 303 (2.7) | ||
| Men | 6,234 (54.8) | 6,234 (54.8) | 0.000 | 1.000 |
| Follow-up (years) | 5.06±3.30 | 5.60±3.29 | −12.352 | <0.001 |
| Mental health diagnosis | ||||
| Insomnia | 2,659 (23.4) | 2,310 (20.3) | 31.355 | <0.001 |
| Depressive disorders | 1,047 (9.2) | 875 (7.7) | 16.811 | <0.001 |
| Dementia | 989 (8.7) | 568 (5.0) | 122.190 | <0.001 |
| Substance use disorders | 175 (1.5) | 111 (1.0) | 14.504 | <0.001 |
| Alcohol use disorders | 226 (2.0) | 89 (0.8) | 60.420 | <0.001 |
| Bipolar disorders | 68 (0.6) | 58 (0.5) | 0.798 | 0.372 |
| Psychotic disorders | 59 (0.5) | 49 (0.4) | 0.930 | 0.335 |
| Major coexisting diseases | ||||
| Hypertension | 10,075 (88.5) | 7,053 (61.9) | 2,151.851 | <0.001 |
| Diabetes | 4,960 (43.6) | 3,044 (26.7) | 707.268 | <0.001 |
| Coronary disease | 5,091 (44.7) | 3,753 (33.0) | 330.979 | <0.001 |
| COPD | 4,933 (43.3) | 4,051 (35.6) | 143.018 | <0.001 |
| Chronic kidney disease | 2,696 (23.7) | 1,916 (16.8) | 165.423 | <0.001 |
| Asthma | 1,950 (17.1) | 1,484 (13.0) | 74.468 | <0.001 |
| Fracture | 2,791 (24.5) | 2,357 (20.7) | 47.277 | <0.001 |
| Osteoporosis | 2,446 (21.5) | 2,170 (19.1) | 20.699 | <0.001 |
| Hyperlipidemia | 2,792 (24.5) | 2,028 (17.8) | 153.617 | <0.001 |
| Charlson comorbidity score | 1.42±1.61 | 0.75±1.44 | 32.856 | <0.001 |
Note: Data shown as mean ± standard deviation or n (%).
Abbreviation: COPD, chronic obstructive pulmonary disease.